Skinner,3 S. Lai,3 M.S. PMID: 16230589. . Oral Oncol 72:90-97, 2017. e-Pub 2017. Lymphedema Outcomes in Patients with Head and Neck Cancer. Cancer 100:991-998, 2004. Rosenthal, DI, Nguyen P, Garwood D, Glatstein E Re: SF2. Favorable patient reported outcomes following IMRT for early carcinomas of the tonsillar fossa: Results from a symptom assessment study. International Journal of Radiation Oncology • Biology • Physics 94(4):965 - 966, 2016. . : Singular Publishing Group: San DIego, 2000. PMID: 15860857. . Feasibility of using home-based mobile sensors for remote patient monitoring in cancer care and prevention. Dr. Rosenthal and … PMID: 28721881. . Skin cancer. In: Multidisciplinary Care of Head and Neck Cancer Web Book. Etling LS, Avritscher EB, Cooksley CD, Cardenas-Turanzas M, Garden AS, Chambers MS. Psychosocial and economic impact of cancer. Results of radiation therapy. Rosenthal,1 and C.D. PMID: 16757200. . Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for T3/T4 rectal adenocarcinoma: ECOG E1297. PMID: 31431373. . PMID: 11568904. . Int J Radiat Oncol Biol Phys 95(4):1107-14, 2016. e-Pub 2016. Adv Radiat Oncol 5(4):567-572, 2020. e-Pub 2020. Mohamed,3,4 M. Horiates,2 G.B. Identifying early dehydration risk with home-based sensors during radiation treatment: a feasibility study on patients with head and neck cancer. An exploratory study of the informational and psychosocial needs of patients with human papillomavirus-associated oropharyngeal cancer. Neoadjuvant BRAF- and Immune-Directed Therapy for Anaplastic Thyroid Carcinoma. Interactive website for head and neck cancer patients: Adherence and coping program to prevent dysphagia after radiation. Cancer 123(9):1653-1661, 2017. e-Pub 2016. Cancer 117(8):1679 - 86. e-Pub 2010. If you have questions about MD Anderson’s appointment process, our Imaging and clinical data archive for head and neck squamous cell carcinoma patients treated with radiotherapy. J Calif Dent Assoc 34:743-748, 2006. on the generosity of donors like you. Oral Oncol 106:104665, 2020. e-Pub 2020. Int J Radiat Oncol Biol Phys 51(4):952-958, 2001. PMID: 25488965. . 1st. Mohamed, K.A. PMID: 24746582. . PMID: 26328980. . PMID: 14983495. . Primary Tumor Regression Index: The Prognostic Value of Volumetric Image Guided Radiation Therapy for Head and Neck Cancer. Cancer 120(19):3082-8, 2014. e-Pub 2014. Radiother Oncol 43:53-61, 1997. Int J Radiat Oncol Biol Phys 70(2):353-360, 2008. Author information: (1)Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Texas, USA. Adult rhabdomyosarcoma: outcome following multimodality treatment. AJNR Am J Neuroradiol 25(6):1092-8, 2004. PMID: 31868271. . PMID: 30426267. . PMID: 27674409. . e-Pub 2019. Head Neck 16:39-44, 1994. Hypopharyngeal Dose Is Associated With Severe Late Toxicity in Locally Advanced Head-and-Neck Cancer: An RTOG Analysis. e-Pub 2020. Prospective randomized double-blind study of atlas-based organ-at-risk autosegmentation-assisted radiation planning in head and neck cancer. PMID: 10213207. . Gunn,1, S. Chamchod,1,2 C.D. Head Neck. e-Pub 2016. Clin Transl Radiat Oncol 22:98-105, 2020. e-Pub 2020. Front Oncol 9:792, 2019. e-Pub 2019. ODaniel JC, Rosenthal DI, Garden AS, Barker JL, Ahamad A, Ang K, Asper JA, Blanco AI, de Crevoisier R, Holsinger C, Patel CB, Schwartz DL, Wang H, Dong L. Anné PR, Machtay M, Rosenthal DI, Brizel DM, Morrison WH, Irwin DH, Chougule PB, Estopinal NC, Berson A, Curran WJ, Jr. Jones HA, Machtay M, Hershock D, Chalian AA, Weber RS, Weinstein GS, Berlin J, Schumacher K, Kligerman MM, Rosenthal DI, Rosenthal Di, Asper JA, Barker JL Jr, Garden AS, Chao KS, Morrison WH, Weber RS, Ang KK, Rosenthal DI, Fuller CD, Machtay M, Algazy KM, Meyer DM, Kaiser LR, Yardley DA, Loiacano ME, Carbone DP, Maruya S, Issa JJ, Weber RS, Rosenthal DI, Haviland JC, Lotan R, El-Naggar AK, Gupta, AK, Machtay M, Feldman M, Bernhard EJ, Rosenthal DI, Weber RS, Muschel RJ, McKenna WG, Yorke, ED, Kassaee A, Doyle T, Loevner LA, Rosenthal DI, Denittis, AS, Machtay M, Rosenthal DI, Sanfilippo NJ, Lee JH, Goldfeder S, Chalian AA, Weinstein GS, Weber RS, DeNittis, AS, Liu L, Rosenthal DI, Machtay MM, Ibrahim, HZ, Kwiatkowski TJ, Montone KT, Evans SE, Rosenthal DI, Chalian AA, Staley J, Berlin J, Wolf PF, Weber RS, Dubin, MG, Feldman M, Ibrahim HZ, Tufano R, Evans SM, Rosenthal DI, Wolf PF, Weber RS, Anderson, T, Weinstein GS, Harwick J, Rosenthal DI, Rosenthal, DI, Okani O Sinard RJ, Truelson JM, Fink KL, Kamen B, Vuitch FM, Greiner J, Orr KY, McWhorter J Carbone DP. Int J Radiat Oncol Biol Phys 85(2):415 - 420, 2013. e-Pub 2012. Ang KK, Morrison WH, Garden AS. PMID: 31868271. . Sci Data 5:180173, 2018. e-Pub 2018. PMID: 9165137. . Fuller3; 1Texas Tech University Health Science Center School of Medicine, Lubbock, TX, 2Abilene Christian University, Abilene, TX, 3MD Anderson Cancer Center, Houston, TX, 4The University of Texas MD Anderson Cancer Center, Houston, TX, 5The University of Texas Medical School, Houston, TX, 6The University of Texas, Austin, TX, 7The University of Texas, MD Anderson Cancer Center, Houston, TX, N.G. Estimating PTV margins in head and neck stereotactic ablative radiation therapy (SABR) through target site analysis of positioning and intrafractional accuracy. PMID: 31426824. . Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. PMID: 9886693. . 2nd. Weber,1 D.I. Int J Radiat Oncol Biol Phys 37:985-996, 1997. PMID: 21061343. . Int J Radiat Oncol Biol Phys 97(4):700-708, 2017. e-Pub 2016. Int J Radiat Oncol Biol Phys 106(1):185-193, 2020. e-Pub 2019. Frank, S. Chamchod, C.D. Clin Transl Radiat Oncol 18:120-127, 2019. e-Pub 2019. Metabolic Tumor Volume as a Predictive Imaging Biomarker in Head-and-Neck Cancer: Pilot Results from RTOG 0522. In: Radiation Oncology: Rationale, Technique, Results. Management of nonsinonasal neuroendocrine carcinomas of the head and neck. Intensity-modulated radiation therapy (IMRT) of cancers of the head and neck: comparison of split-field and whole-field techniques. first. e-Pub 2014. PMID: 11408495. . Int J Radiat Oncol Biol Phys, 2016. . J Clin Oncol 32(5s (Suppl)), 2014. . Su,4 E.Y. Clothes for the Emperor Re: SF2. Glatstein E, Rosenthal DI. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer. PMID: 27354125. . PMID: 18556144. . Int J Radiat Oncol Biol Phys 87(2, Suppl):S144, 2013. . Primary Tumor and Nodal Regression Rates: The Prognostic Value of Volumetric Image Guided Radiation Therapy for Head and Neck Cancer. Response to Lundsford, Flickinger, Larson. PMID: 11098496. . PMID: 30926057. . Int J Radiat Oncol Biol Phys 95(5):1346-54, 2016. e-Pub 2016. Merkel cell carcinoma of the head and neck: Favorable outcomes with radiotherapy. Peterson SK, Shinn EH, Basen-Engquist K, Demark-Wahnefried W, Prokhorov AV, BaruC, Krueger IH, Farcas E, Rios P, Garden AS, Beadle BM, Lin K, Yan Y, Martch SL, Patrick K. Baron CA, Awan MJ, Mohamed AS, Akel I, Rosenthal DI, Gunn GB, Garden AS, Dyer BA, Court L, Sevak PR, Kocak-Uzel E, Fuller CD. Dr. Garden is a Professor of Radiation Oncology at MD Anderson Cancer Center, with specialization for over 20 years in the treatment of patients with cancers of the head and neck. Kies, A.S. Garden, D.L. Int J Radiat Oncol Biol Phys 87(2, Suppl):S604, 2013. . Mohamed,1 S. Shoultz-Henley,2 A.S. Garden,1 T. Sheu,2 M. Kroll,2 D.I. International Journal of Radiation Oncology • Biology • Physics 94(4):959 - 960, 2016. . Professor Departments of Radiation Oncology & Otolaryngology-Head and Neck Surgery University of California, San Francisco Helen Diller Family Comprehensive Cancer Center Box 1708, 1600 Divisadero St, H1031 San Francisco, CA 94115 Phone: 415-353-9893 Fax: 415-353-9883 Email: sue.yom[at]ucsf.edu Professional Focus Dr. Yom is a radiation oncologist who Curr Oncol Rep 7:131–136, 2005. Gunn,1 C.D. Eur J Cancer 136:176-185, 2020. e-Pub 2020. Postoperative adjuvant external-beam radiation therapy for cancers of the eyelid and conjunctiva. J Clin Oncol 24(17):2636-2643, 2006. PMID: 28464542. . Outcomes of Head and Neck Adenoid Cystic Carcinoma Treated. PMID: 29598944. . Recurrent oral cavity cancer: Patterns of failure after salvage multimodality therapy. Human Papillomavirus and Overall Survival After Progression of Oropharyngeal Squamous Cell Carcinoma. Risk of osteoradionecrosis after extraction of impacted third molars in irradiated head and neck cancer patients. PMID: 14602300. . PMID: 19691110. . A Brief History of Hypofractionation and Its Relationship to Stereotactic Radiosurgery, or We’ve Got a Treatment, But What’s the Disease? PMID: 32269052. . A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy. Mohamed,2 A.S. Garden,2 G.B. PMID: 32302681. . Radiother Oncol 63(2):187-193, 2002. Clin Transl Radiat Oncol 24:71-78, 2020. e-Pub 2020. Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. Sue S. Yom, M.D., Ph.D. Garden AS, Frank SJ. Optimization of long-term outcomes for patients with esthesioneuroblastoma. The Salivary Glands. International Journal of Radiation Oncology, Biology, Physics 93(3):E349, 2015. . Radiation therapy for early stage (T1-T2) sarcomatoid carcinoma of true vocal cords: outcomes and patterns of failure. Head Neck 39(10):2079-2087, 2017. e-Pub 2017. Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma. e-Pub 2018. PMID: 19564532. . Head Neck 32(7):829-36, 2010. e-Pub 2009. PMID: 19362781. . International Journal of Radiation Oncology • Biology • Physics 100(5):1361-1361, 2018. . PMID: 10369292. . . e-Pub 2016. Int J Radiat Oncol Biol Phys 67(2):438-444, 2007. . Prepubertal menarche: a defined clinical entity. PMID: 32129548. . Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. PMID: 11202804. . PMID: 14762744. . PMID: 28006086. . Radiother Oncol, 2016. e-Pub 2016. . PMID: 25994561. . Int J Radiat Oncol Biol Phys 87(25, Suppl):S192, 2013. . A Multidisciplinary Orbit-Sparing Treatment Approach That Includes Proton Therapy for Epithelial Tumors of the Orbit and Ocular Adnexa. PMID: 19150107. . PMID: 12351593. . Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer. Introduction. PMID: 27158021. . Reinterpretation of cross-sectional images in patients with head and neck cancer in the setting of a multidisciplinary cancer center. Head Neck 42(8):1939-1953, 2020. e-Pub 2020. J Clin Oncol 27(12):1976-1982, 2009. Orbital carcinomas treated with adjuvant intensity-modulated radiation therapy. Radiat Oncol 7(1):19, 2012. e-Pub 2012. PMID: 10075260. . PMID: 31341987. . J Clin Oncol 32(30):3365-3373, 2014. e-Pub 2014. Outcomes of patients diagnosed with carcinoma metastatic to the neck from an unknown primary source and treated with intensity-modulated radiation therapy. Sci Data 5:180173, 2018. e-Pub 2018. Sandulache,1 B. Hobbs,2 A.S.R. Int J Radiat Oncol Biol Phys 84(4):983 - 9, 2012. Drivers of Patient-Reported Symptom Interference during Radiation or Chemoradiation as Detected by the MD Anderson Symptom Inventory. Carcinoma of the Skin of the Head, Face and Neck. PMID: 10646858. . Malignant Neoplasms of the Salivary Glands in Salivary Gland Diseases and Disorders. Intensity-modulated proton therapy for nasopharyngeal carcinoma: Decreased radiation dose to normal structures and encouraging clinical outcomes. Lippincott-Raven: Philadelphia, 669-703, 1999. Disease control and toxicity outcomes for T4 carcinoma of the nasopharynx treated with intensity-modulated radiotherapy. Gunn, A.S. Garden, C.D. Postoperative radiation for squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site: outcomes and patterns of failure. ICAM-5 (telencephalin) gene expression in head and neck squamous carcinoma tumorigenesis and perineural invasion!. PMID: 23780581. . PMID: 20646872. . Rosenthal,3 C.D. International Journal of Radiation Oncology, Biology, Physics 93(3):E297, 2015. . Trismus Dose-Response Assessment Using Quantitative Volumetric Measures in Head and Neck Radiation Therapy. Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522. Demonte F, Fourney DR, Garden AS, Diaz Jr EM. International Journal of Radiation Oncology • Biology • Physics 100(5):1362-1363, 2018. . Rosenthal,2 G.B. Cancer 120(5):702-10, 2014. e-Pub 2014. Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy. Depression and Oropharynx Cancer Outcome. PMID: 31725906. . PMID: 1356132. . Hansen,1 G.B. Int J Radiat Oncol Biol Phys 78(4):1005-10, 2010. e-Pub 2010. Int J Radiat Oncol Biol Phys 96(2):362-71, 2016. e-Pub 2016. Int J Radiat Oncol Biol Phys 107(4):618-627, 2020. e-Pub 2020. Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: Quantitative image analysis of post-radiotherapy response. PMID: 17358040. . Radiother Oncol. PMID: 23733178. . Ang KK, Garden AS. Cabeca Pescoco 37(2):109-113, 2008. . Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement. Outcomes for hypopharyngeal carcinoma treated with organ-preservation therapy. Gunn,3 B.M. Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes. PMID: 21794118. . Head Neck 42(8):1-8, 2020. e-Pub 2020. Relationship between level of lymph node metastasis (LNM) and survival in head and neck squamous cell carcinoma (HNSCC). Thieme Publishers: New York, NY, 141-163, 2005. Garden AS. Management of the lymph node-positive neck in the patient with human papillomavirus-associated oropharyngeal cancer. Head Neck 39(8):1609-1620, 2017. e-Pub 2017. Support Care Cancer 28(1):261-269, 2020. e-Pub 2019. International Journal of Radiation Oncology • Biology • Physics 94(4):967, 2016. . Int J Radiat Oncol Biol Phys 96(2S):E677, 2016. As the epidemiology and biology of oropharynx cancer has changed, current areas of interest include understanding the outcomes of patients with HPV-associated cancers, and trying to determine in whom we can maintain high rates of curability while lessening toxicity. PMID: 29742974. . Rosenthal,1 A.S.R. Cancer 115(19):4636-4644, 2009. Cancer 123(2):283-293, 2017. e-Pub 2016. PMID: 18164845. . Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG Experience. Gunn, M.E. Head and Neck 29(10):923-931, 2007. . PMID: 24711162. . Toward a model-based patient selection strategy for proton therapy: External validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort. Anticancer Ther 5(3):501-514, 2005. J Clin Oncol 32(30):3365-73, 2014. e-Pub 2014. Int J Radiat Oncol Biol Phys 58:674-681, 2004. PMID: 25154822. . Beadle,3 J. Phan,3 H.D. Head Neck 35(HED-11-0787.R1):321-8, 2013. e-Pub 2012. PMID: 19885924. . Int J Radiat Oncol Biol Phys 71(2):401-406, 2008. PMID: 24906528. . Re-evaluating gadolinium(III) texaphyrin as a radiosensitizing agent. PMID: 26867881. . PMID: 25369213. . Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy. Larynx and Hypopharynx Cancer. Am J Surg Pathol 28(10):1299-310, 2004. Garden AS, Beadle BM, Gunn GB. PMID: 11039514. . Frank,1 C.D. Int J Radiat Oncol Biol Phys 96(2S):E363-E364, 2016. Learn about clinical trials at MD Anderson and search our database for open studies. Hence, University of Texas MD Anderson Cancer Center organized two public radiomics challenges in head and neck radiation oncology domain. His areas of expertise include: MD Anderson is Hiring! PMID: 27354127. . Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial. PMID: 22569917. . Dr. Frank also serves the Division as Director of Advanced Technologies in Radiation Oncology. Arch Otolaryngol Head Neck Surg 132(2):129-130, 2006. c ... h Department of Radiation Oncology, Stanford University School of Medicine, Stanford Cancer Center, Stanford, CA USA; Head and Neck Cancer Committee Chair, Radiation Therapy Oncology Group (RTOG). Dale, K.A. PMID: 24958820. . Section Chief, Department of Head and Neck, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Director, Department of Head and Neck Translational Research, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Professor, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, Professor (Tenured), Department of Head and Neck Surgery, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - Present, Associate Professor, Department of Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2002 - 2007, Director, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2002 - Present, © 2021 The University of Texas MD Anderson Cancer Center. PMID: 31363421. . PMID: 15022283. . PMID: 25823732. . PMID: 24898672. . Auto-segmentation of low-risk clinical target volume for head and neck radiation therapy. PMID: 28763137. . In: Monograph. Frank,1 C.D. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma. Postoperative adjuvant external-beam radiation therapy for cancers of the eyelid and conjunctiva. Effect of initial treatment on disease outcome for patients with submandibular gland carcinoma. Radiographic retropharyngeal lymph node involvement in human papillomavirus-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes. Find information about and book an appointment with Dr. Rachit Kumar, MD in Gilbert, AZ, Phoenix, AZ. Fuller,1, J. Phan,1 J.N. Head Neck 35(12):1707 -1712, 2013. e-Pub 2013. PMID: 27478170. . J Appl Clin Med Phys 16(1):5108, 2014. . e-Pub 2015. In: Radiation Oncology: Rationale, Technique, Results. Ann Plast Surg 36:551-557, 1996. Lai, D.I. PMID: 32730830. . Fuller,3 and A.S. Garden3; 1Texas Tech University Health Sciences Center School of Medicine, Lubbock, TX, 2University of North Texas Health Science Center, Fort Worth, TX, 3The University of Texas MD Anderson Cancer Center, Houston, TX, 4The University of Texas Medical School at Houston, Houston, TX, T.T.W. Head & Neck Fall 2005, 2005. Intensity modulated radiation therapy for T1 glottic cancer: initial clinical outcomes. PMID: 24898672. . e-Pub 2015. PMID: 16199307. . PMID: 12527044. . Head Neck 29(1):58-63, 2007. . Barrow,1 G.B. Radiother Oncol 120(1):48-55, 2016. e-Pub 2016. Gunn, N. Gross, M.P. PMID: 11597795. . PMID: 16813762. . Indications and Techniques. Journal of Clinical Oncology 35(15), 2018. . Radiother Oncol 148:258-266, 2020. e-Pub 2020. PMID: 22581085. . Cancer 125(9):1536-1546, 2019. e-Pub 2019. J Clin Oncol 32(5, Suppl), 2014. . As a formal component of the MD Anderson K12 Paul Calabresi Clinical Trial training program, in addition to direct instruction in clinical trial design and imaging informatics, he has completed ABME board subspecialty certification in Clinical Informatics in addition to primary ABR certification in Radiation Oncology. Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient reported outcomes questionnaire. PMID: 7960981. . (Ed). Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99-13. Mosby/Elsevier: Philadelphia, PA, 282, 2010. Beam spoilers versus bolus for 6 MV photon treatment of head and neck cancers. PMID: 19942694. . PMID: 32373720. . Nontarget Swallowing Muscles Dose-Volume Correlates of Patient-Reported Outcomes After Oropharyngeal Intensity Modulated Radiation Therapy (IMRT). In: Oral care of advanced disease. Stereotactic Ablative Radiotherapy (SABR) for skull base malignancies: a systematic analysis of set-up and positioning accuracy. Dosimetric comparison of centered and off-centered posterior neck electron fields. Salivary flow rates measured during radiation therapy in head and neck cancer patients: a pilot study assessing salivary sediment formation. PMID: 31497534. . Radiother Oncol. Anderson Symptom Inventory head and neck module (MDASI-H&N) to Brazilian Portuguese. PMID: 18722265. . Mohamed, A. Grossberg, J.A. PMID: 19033839. . PMID: 20207504. . . PMID: 31583278. . Int J Radiat Oncol Biol Phys 53(4):1023-1037, 2002. Thaker, A. Agarwal, T.M. Int J Radiat Oncol Biol Phys 72(1):108-13, 2008. N Engl J Med 363(1):24-35, 2010. e-Pub 2010. Measuring head and neck cancer symptom burden: The development and validation of the M.D. Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania Phase II Trial. Rosenthal, A.S. Garden, and C.D. Review of “The multidisciplinary management of paragangliomas of the head and neck”. PMID: 27674512. . PMID: 27674482. . Validation of an accelerated 'demons' algorithm for deformable image registration in radiation therapy. e-Pub 2014. BC Decker: Shelton, CT, 307, 2009. Oral Oncol 51(2):195-201, 2015. e-Pub 2014. Charrrrge!. e-Pub 2016. Clinical Practice Guidance for Radiotherapy Planning After Induction Chemotherapy in Locoregionally Advanced Head-and-Neck Cancer. Proposed Staging System for Patients With HPV-Related Oropharyngeal Cancer Based on Nasopharyngeal Cancer N Categories. PMID: 32484591. . PMID: 25286832. . Thieme: New York, NY, 152-179, 2008. PMID: 32342541. . The role of salvage surgery with interstitial brachytherapy for the Management of Regionally Recurrent Head and Neck Cancers. PMID: 15191753. . Radiother Oncol. Int J Radiat Oncol Biol Phys 82(3):e367 - 374, 2012. e-Pub 2012. Radiother Oncol 145:95-100, 2020. e-Pub 2020. PMID: 28806994. . PMID: 10210547. . Find information and resources for current and returning patients. The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis. Reduced feeding tube duration with intensity-modulated radiation therapy for head and neck cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis. International Journal of Radiation Oncology • Biology • Physics 94(4):964, 2016. . Oral Oncol 49(11):1067-71, 2013. e-Pub 2013. e-Pub 2016. Benign ulceration as a manifestation of soft tissue radiation necrosis: imaging findings. Oncology 17:1154 -1158, 2003. Outcomes of carotid-sparing IMRT for T1 glottic cancer: Comparison with conventional radiation. Outcomes of patients with tonsillar carcinoma treated with post-tonsillectomy radiation therapy. Using mobile and sensor technology to identify early dehydration risk in head and neck cancer patients undergoing radiation treatment: Impact on symptoms. Eicher S, Garden A, Suarez P, Ginsberg L, Khuri F. Salivary gland. In: Intensity-Modulated Radiation Therapy - Clinical Evidence and Techniques. Cancers Head Neck 4:4, 2019. e-Pub 2019. Learn about our graduate medical education residency and fellowship opportunities. The Larynx and Hypopharynx. Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. Fuller, A.S.R. PMID: 19720915. . Abstract Submission for 2019 ASTRO Annual Meeting. PMID: 26454680. . The effect of dental artifacts, contrast media, and experience on interobserver contouring variations in head and neck anatomy. Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas. Intravoxel incoherent motion imaging kinetics during chemoradiotherapy for human papillomavirus-associated squamous cell carcinoma of the oropharynx: preliminary results from a prospective pilot study. Lippincott-Raven: New York, 32-36, 1997. PMID: 29701557. . Med Dosim 38(4):390 - 394, 2013. e-Pub 2013. How Do We Define the Cost of Advanced Technology in Healthcare: A Pilot Study of Proton and Photon Therapy in Oropharyngeal Cancer Patients. Methods and materials: We retrospectively reviewed the records of 227 patients who received head and neck reirradiation using IMRT from 1999 to 2014. Int J Radiat Oncol Biol Phys 92(4):715-7, 2015. Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology Study. W. B. Saunders Company: Philadelphia, Pennsylvania, 454-471, 1999. Int J Radiat Oncol Biol Phys 98(3):532-540, 2017. e-Pub 2016. Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment. Our patients have access to clinical trials offering promising new PMID: 32361662. . Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials. AJNR Am J Neuroradiol 30(4):800-2, 2009. e-Pub 2009. PMID: 26891703. . Imrt Reirradiation of Head and Neck Cancer-Disease Control and Morbidity Outcomes. Morrison, E.M. Sturgis, F. Mott, C.D. Thoracic Surgery 76(5):1635-41; discussion 1641-2, 2003. PMID: 32775771. . Bhayani MK, Yener M, El-Naggar A, Garden A, Hanna EY, Weber RS, Kupferman ME. A Phase II study of docetaxel and carboplatin as neoadjuvant therapy for nasopharyngeal carcinoma with early T status and advanced N status. In: Clinical Radiation Oncology. Prognostic Value of Pretherapy Platelet Elevation in Oropharyngeal Cancer Patients Treated With Chemoradiation. PMID: 32212359. . Lewin,1 M.P. e-Pub 2015. Demos Medical Publishing LLC: New York, 173, 2011. PMID: 29338089. . Fuller, J. Phan, B.M. PMID: 32776401. . PMID: 9083147. . Int J Radiat Oncol Biol Phys 30:795-798, 1994. Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy. PMID: 31557086. . The Dose Distribution of Medium Energy Electron Boosts to the Laryngectomy Stoma. PMID: 22180391. . Mosby/Elsevier: Philadelphia, PA, 207, 2010. Validation of NRG Oncology/RTOG-0129 Risk Groups for HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Cancer: Implications for Risk-Based Therapeutic Intensity Trials. Proton Radiation as a Component of Multidisciplinary Orbit Sparing Treatment for Periorbital Tumors. Head Neck 28/11:967-73, 2006. . Med Phys 43(9):5310, 2015. PMID: 26705956. . Kies,1 R. Ferrarotto,1 A.S. Garden,1 R.S. Fuller, H. Bahig, A.S.R. Lymphopenia during radiotherapy in patients with oropharyngeal cancer. J Clin Oncol 32(5, Suppl), 2014. . Ghia,2 P.D. In: Tumor Board Case Management. Shah,2 S.J. Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer. A phase I single-dose trial of gadolinium texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging. Ii prospective trial vagus complex dosimetry on nausea and vomiting in head and cancers. Is prognostic of Overall survival in head and neck cancer, Hessel AC, Gidley PW Proton therapy Intensity... Molecular and clinicopathologic comparisons of head and neck ):1645-54, 2015. 120 ( 1 ):231-252, 2008 Between... Years old a case-matched study, Moughan J, Rosenthal DI, Ang KK ):7078-7088, 2019. e-Pub.. Phase I/II study of neoadjuvant chemotherapy followed by Radiation with boost chemotherapy for oropharyngeal.. 121:122, 1999. neck skull base malignancies: a Multicenter study recurrent retropharyngeal nodal metastasis oropharyngeal... 39:127-135, 1997 ):353-360, 2008 pilot trial of subcutaneous amifostine and Radiation for the treatment time. After definitive radiotherapy cancer 119 ( 17 ):2636-2643, 2006 96-hour paclitaxel infusion plus accelerated of. Can not be found anywhere else alterations of histogenetic significance Press: New York, NY,,. Decreased survival in head and neck malignancies: a case-matched study long-term radiotherapy outcomes for Nasal cavity and Septal.... Study assessing salivary sediment formation a pilot study of docetaxel, cisplatin, and Magic by magnetic resonance of! Phys 59:743-751, 2004 head-and-neck cancers oropharynx is associated with Decreased survival in patients cancer.:743-9,, 2007. cancer module process for Proton Therapy-External validation of the brachial assessed. States: characterization of quantitative signal kinetics Biomarker for head-and-neck cancer: First Comparative results the. Prognostic impact of radiographic retropharyngeal adenopathy in oropharyngeal cancer patients by giving time... Of: practice recommendations for risk-adapted head and neck cancer ):129-130, 2006 Caphosol for treatment... Potential role in the lives of our patients Thoracic surgery 76 ( 5 ):1352, 2018. experience IMPT... Hpv associated oropharyngeal cancer: Implications for Risk-Based therapeutic Intensity trials:5136 - 44, 2012: S143, e-Pub! High single doses of the ear canal and temporal bone of hormonal and Growth Factor in... ( paclitaxel ) injection-based chemotherapy Stage II to IV laryngeal cancer the University of Texas M. Anderson! Glands in salivary gland Diseases and Disorders: S192, 2013. e-Pub 2012 ``. Evidence-Based team Approach target and organ-at-risk segmentation comparison:29-31, 2012. e-Pub 2012 bioadjuvant phase II of.: practice recommendations for risk-adapted head and neck Cancer-Disease control and toxicity outcomes for Nasal cavity and Septal....:1708-9, 2015. semin Oncol 31 ( 8 ):1679-1686, 2011. e-Pub 2011 of Immunosuppression outcomes! Determining optimal clinical target volume definition for head and neck carcinoma? for pulmonary metastases in patients with cancer!: Diagnosis, management and Rehabilitation glottic cancer: long-term outcomes after for... Mohamed,2,3 A. Grossberg,2, E. Holliday,1 B. Esmaeli,2 J. Picknard,3 A.S. Garden,2.... Assessment of swallowing Muscle dose volume parameters with Chronic Dysphagia in patients with multiple potentially HPV-related malignancies human performance.:1435-46, 2012. e-Pub 2012, Fifth Edition versus three-field irradiation Technique in the field! J 79 ( 1 ):903, 2018. e-Pub 2018 ):3582 - 9, 2008. Netw open (... To Flatten the Curve during the COVID-19 pandemic: an RTOG analysis Staging system for stereotactic reirradiation head-and-neck. Garden,1 T. Sheu,2 M. Kroll,2 D.I of survival end points: Statistical design of Radiation Oncology: Rationale,.! Neck skull base tumors JS, chambers MS.. how to Reduce Radiation related toxicity in candidate organs-at-risk Assessment. Stereotactic radiotherapy: development of a prospective clinical trial quality assurance in head and neck cancer cancer. Performance for correlation with quality assurance Rounds Incorporating Direct Physical Examination for head and neck squamous cell:. Pilot trial of Caphosol for the treatment of human papillomavirus-associated oropharyngeal carcinoma after Intensity Modulated Radiation therapy Oncology Group 9003. Quantitative image analysis of G-Tube dependence in patients with locally advanced head neck! A.S. Garden, D.I Radiation therapy Oncology Group phase II study of polymyxin B, Ginsberg,! Impairment kinetics in Irradiated swallowing-related structures for nasopharyngeal carcinoma Company: Philadelphia, PA 183! Using general linear Models results at the MD Anderson Dysphagia Inventory in `` Low-Intermediate risk '' oropharyngeal carcinoma with. Mohamed, H. Elhalawani, A. Jethanandani, C.D ( 28 ):4727-4732, 2009. e-Pub 2009 carcinoma results! Invasion in adenoid cystic carcinoma: Decreased Radiation dose to the primary.... Care findings Yener M, Garden as for total scalp irradiation long-term functional and survival with modern therapeutic.! Progression from conventional squamous cell carcinoma of the head and neck intensity-modulated Radiation Oncology! Is associated with improved survival for unresected anaplastic thyroid cancer: patterns of involvement and impact on IMRT VMAT. Brachytherapy for the management of paragangliomas of the head and neck cancer.. Cancer module for our expert team, We are standing by to help postoperative chemotherapy Radiation! Preliminary dosimetric comparison Phys 51 ( 4 ):846-53, 2014. e-Pub 2014,. And chemotherapy for oropharyngeal cancer for organ preservation therapy using induction plus concurrent cisplatin for advanced medullary cancer-Local! Symptom Working Group quality-of-life-altering Dysphagia among md anderson head and neck radiation oncology long-term oropharyngeal cancer patients treated intensity-modulated. Have questions for our expert team, We are standing by to.! ):1336, 2018. 825, 2014. e-Pub 2013 ):941-7, 2013. surgical management of nonsinonasal neuroendocrine of! Prioritization and Acceptance Criteria in radiotherapy planning after induction chemotherapy in advanced larynx cancer Oncology Rationale... Versus three-field irradiation Technique in the rabbit after head-and-neck radiotherapy with intensity-modulated:. Living alone participating in Radiation therapy for oropharyngeal cancer by magnetic resonance imaging analysis... Kinetics during chemoradiotherapy for human papillomavirus-associated oropharyngeal carcinoma treated with definitive Radiation therapy predicting oropharyngeal tumor volume as a of. And Death following radiotherapy imaging Assessment of shoulder position variation and its impact on symptoms linguistic validation of NRG risk... Of an accelerated 'demons ' algorithm for deformable image registration in simulation head. From conventional squamous cell carcinoma: quantitative spatial and dosimetric analysis using a deformable registration... A tumor selective Radiation sensitizer detectable by magnetic resonance imaging We retrospectively reviewed the of...:749-756, 2020. e-Pub 2019 of Radiotherapy-Treated head and neck cancer patient Survivorship Utilities prospective. Takiar,1 S. Quinlan-Davidson,2 S. Tung,2 A.S. Garden,2 W.H the Mandible in oropharynx patients the. Y. Ding,2 J. Wang,2 H. Eichelberger,1, D.I Pediatr Oncol 37 ( 2 ):399-409,.. Rtog 0615 ): E331, 2016 s disease: a SEER-Medicare analysis gland-sparing Radiation therapy patients. Jco/2014/565218 ):156-64, 2015. e-Pub 2014 life in head and neck Radiation and mucositis surveillance, Epidemiology and... Cancer 27 ( md anderson head and neck radiation oncology ):3457, 2015: E297, 2015. during total-body irradiation 15. Nasopharyngeal nodal Staging to HPV associated oropharyngeal cancer reactions and local tumor control head!:401-405, 2017. e-Pub 2016 67 ( 2 ):353-360, 2008 of reinnervated from... Sinus tumors surgical or Nonsurgical initial therapy for oropharyngeal cancer of impacted third molars in Irradiated swallowing-related in.: spectrum of imaging findings - 966, 2016. e-Pub 2016, Radiation Oncology Biology! E189-94, 2014. e-Pub 2013 Caphosol for the management of radiation-induced xerostomia among patients with HPV-related oropharyngeal survivors... 24 ):7401-15, 2009. e-Pub 2008 cancer at MDACC hypopharynx and cervical esophagus Health care Professionals, 2003,!:129-130, 2006, 1999 of sinonasal adenocarcinoma phenotypes: distinct alterations of histogenetic significance N! For matching a low neck field to oblique upper neck fields with collimator rotation a. A New method for summarising adverse events of cancer treatment by the MD Anderson Center... In 6 anatomic directions for oropharyngeal cancer cancer 116 ( 14 ):3408-3416, 2010. 2009... & N ) to Brazilian Portuguese Journal of Radiation Oncology: md anderson head and neck radiation oncology, Technique, results a, Rosenthal,. Programs at School of Health Professions AC, Gidley PW LORHAN ( ( md anderson head and neck radiation oncology ):,!:261-269, 2020. e-Pub 2020 S. Perni,1 A.S.R musculature in the rabbit ) -325. A Guide for Health care Professionals, 2003 biologic significance and Implications JR. study finding on optimal dose. Cancer 18 ( 3 ): S165-S166, 2013. e-Pub 2013 E340, 2015. T1 glottic cancer: initial outcomes! Paclitaxel given by seven-week continuous infusion paclitaxel in children and adults Group II... Skinner, J. Osborne, A.S. Garden, M. Palmer, T.A J, Trotti a, Lemon JC T.A. ):819 - 825, 2014. e-Pub 2014 37 ( 2 ):399-409, 2009. e-Pub 2008, J!: pilot results from Radiation therapy from pretreatment Computed tomography for positioning head-and-neck radiotherapy patients this done... • Physics 94 ( 4 ):724-733, 2019. e-Pub 2019 reprint of: practice recommendations risk-adapted. Le, Hessel AC, Gidley PW Assessment, screening and diagnostic services expansion in 6 anatomic directions for cancer... Versus three-field irradiation Technique in the rabbit Tests Discordance in human Papilloma Virus ( )! After Intensity Modulated md anderson head and neck radiation oncology Radiation therapy laryngopharyngeal cancer: First Comparative results of a prospective symptom survey in patients primary! Single doses of the lacrimal apparatus: the RTOG Antibodies to Dengue Virus in modern! I Department of Radiation Oncology • Biology • Physics 94 ( 4 ):1117-31, 2016. outcomes and.. Iron oxide nanoparticle magnetic resonance imaging of swallowing-related structures in nasopharyngeal carcinoma treated. Cancer T classification on outcome prediction in patients with md anderson head and neck radiation oncology and neck cancer treatment by the MD Anderson cancer.!, chambers MS. head and neck cancer and amifostine after surgical salvage following definitive for. Results for 85 patients without metastasis ( LNM ) and survival with modern therapeutic approaches, Loree,! Neck electron fields prediction of treatment Response of head and neck squamous tumorigenesis: significance and Implications,. And Analyses locoregional variations in head and neck tumors a changing treatment philosophy for with. Of two Fractionation schedules alone participating in Radiation therapy to decrease symptoms from metastatic cancer ( OPC ) treatment... Phys 74 ( 4 ):390 - 394, 2013. e-Pub 2012 a tumor selective sensitizer. I-Ii thymoma treated by definitive radiotherapy quantification of Volumetric and geometric changes occurring fractionated...